| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/16/2006 | US20060057186 Oral contraceptive multivitamin compound and methods of administration |
| 03/16/2006 | US20060057185 Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person |
| 03/16/2006 | US20060057179 Therapeutic polyesters and polyamides |
| 03/16/2006 | US20060057167 Storable and shippable concentrates; mixable with polymer formulations without heating, homogenizing or cooling |
| 03/16/2006 | US20060057147 Antibody recognizing antibody |
| 03/16/2006 | US20060057131 Malleable protein matrix and uses thereof |
| 03/16/2006 | US20060057115 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
| 03/16/2006 | US20060057106 Freeze-dried interferon-y composition for transpulmonary administration and inhalation system therefor |
| 03/16/2006 | US20060057103 A mutein of IL-15 at least one deletion or substitution in two positions of the amino acid sequence; transplant rejection, autoimmune diseases, inflammatory bowel disease, skin disorders, gatrointestinal disorders, vision defects; antiarthritic, anticarcinogenic, and antidiabetic agents |
| 03/16/2006 | US20060057099 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 03/16/2006 | US20060057063 Therapy of cancer, diagnosis, imaging; drug conjugate; targeting agent and an anti-cancer agent, wherein targeting agent comprises an erythropoietin receptor ligand |
| 03/16/2006 | DE102004045037A1 Pharmazeutische Darreichungsformen mit erschwerter Extrahierbarkeit eines Sympathomimetikums aus der Darreichungsform Pharmaceutical dosage forms with aggravated extractability of a sympathomimetic agent from the dosage form |
| 03/16/2006 | CA2579488A1 Glycosylceramide adjuvant for saccharide antigens |
| 03/16/2006 | CA2579102A1 Compositions and methods for the diagnosis and treatment of tumor |
| 03/16/2006 | CA2578225A1 Testosterone gels comprising propylene glycol as penetration enhancer |
| 03/16/2006 | CA2577786A1 Endogenously-formed conjugate of albumin |
| 03/16/2006 | CA2577490A1 Prodrugs containing alkyldisulfide linker groups |
| 03/16/2006 | CA2519418A1 New injectable formulations containing progesterone |
| 03/15/2006 | EP1634908A1 Cellulose powder |
| 03/15/2006 | EP1634589A1 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 03/15/2006 | EP1634587A2 Film preparation for biphasic release of pharmacologically active or other substances |
| 03/15/2006 | EP1634585A1 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle |
| 03/15/2006 | EP1634584A1 Dimeticone-containing sustained formulation |
| 03/15/2006 | EP1634583A1 Testosterone gels comprising propylene glycol as penetration enhancer |
| 03/15/2006 | EP1634499A1 Aqueous compositions for disinfection and/or sterilization |
| 03/15/2006 | EP1633800A1 Polyamino acids functionalised with at least one hydrophobic group and applications thereof particularly therapeutic applications |
| 03/15/2006 | EP1633785A2 Human monoclonal antibodies against bacillusanthracis protective antigen |
| 03/15/2006 | EP1633784A2 Ovr110 antibody compositions and methods of use |
| 03/15/2006 | EP1633778A1 Poly-gamma-glutamic acid conjugates for eliciting immune responses directed against bacilli |
| 03/15/2006 | EP1633388A2 Liquid stabilized protein formulations in coated pharmaceutical containers |
| 03/15/2006 | EP1633382A2 Repeat sequence protein polymer active agent conjugates, methods and uses |
| 03/15/2006 | EP1633380A2 Antimicrobial and anticancer lipopeptides |
| 03/15/2006 | EP1633368A2 Foamable pharmaceutical compositions and methods for treating a disorder |
| 03/15/2006 | EP1633334A2 A method of promoting sleep using topical administration of vasoactive agents |
| 03/15/2006 | EP1633327A1 Method for improving stability and shelf-life of liposome complexes |
| 03/15/2006 | EP1633326A1 Transnasal microemulsions containing diazepam |
| 03/15/2006 | EP1633310A2 Thiotungstate analogues and uses thereof |
| 03/15/2006 | EP1590004A4 Improved thickened beverages for dysphagia |
| 03/15/2006 | EP1521595B1 Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase |
| 03/15/2006 | EP1435908A4 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof |
| 03/15/2006 | EP1404303A4 Stable pharmaceutical compositions containing pravastatin |
| 03/15/2006 | EP1401435B1 Topical application of thiazolyl amides |
| 03/15/2006 | EP1339414A4 L-histidine in ophthalmic solutions |
| 03/15/2006 | EP1324749B1 Medicinal aerosol formulations |
| 03/15/2006 | EP1263426B1 Preparations for the non-traumatic excision of a nail |
| 03/15/2006 | EP1250130A4 Propofol formulation with enhanced microbial inhibition |
| 03/15/2006 | EP1227802B1 Film preparation for biphasic release of pharmacologically active or other substances |
| 03/15/2006 | EP1225873B1 Amphiphilic polymeric vesicles |
| 03/15/2006 | EP1162997B1 Staphylococcus antigen and vaccine |
| 03/15/2006 | EP1063885B1 Xylitol compositions for treating upper respiratory conditions |
| 03/15/2006 | EP1044022B1 Compositions and methods for targeted delivery of factors |
| 03/15/2006 | EP1028710A4 Topical compositions for nsai drug delivery |
| 03/15/2006 | EP0956859B1 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 03/15/2006 | CN1747988A Multifunctional dendrimers and hyperbranched polymers as drug and gene delivery systems |
| 03/15/2006 | CN1747771A Method of reducing impurity content in aqueous salt solution |
| 03/15/2006 | CN1747748A Polymer derivatives having particular atom arrangements |
| 03/15/2006 | CN1747747A Aprotinin and analogs as carriers across the blood-brain barrier |
| 03/15/2006 | CN1747746A Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 03/15/2006 | CN1747737A Carbohydrate conjugates to prevent abuse of controlled substances |
| 03/15/2006 | CN1747719A Topical compositions and methods for treating pain |
| 03/15/2006 | CN1747656A Packaging and dispensing of rapid dissolve dosage form |
| 03/15/2006 | CN1746207A Fat ester carbonate polymer with side carboxy, its synthesis and use thereof |
| 03/15/2006 | CN1745848A Chitin-sodium alginate packed pylorus helicobacterium protein microballs and their preparation |
| 03/15/2006 | CN1745754A Airphosphosodium clathrate compound and its preparation |
| 03/15/2006 | CN1745746A Hydroxypropyl-beta-cyclodextrin coating material of borneol an dits preparing method |
| 03/15/2006 | CN1245517C Amphoteric protein paster |
| 03/15/2006 | CN1245450C Polymeric hydrogel |
| 03/15/2006 | CN1245216C Stabilized liquid polypeptide-containing. pharmaceutical compositions |
| 03/15/2006 | CN1245207C Modified technique for making zedoary turmeric oil and glucose injection |
| 03/15/2006 | CN1245166C Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| 03/15/2006 | CN1245158C 片剂组合物 Tablet composition |
| 03/15/2006 | CN1245156C Methods for in vivo delivery of biologics and compositions therefor |
| 03/15/2006 | CN1245154C Mouth cavity fast disintegrating tablet of Chinese medicine or natural medical matters and its preparing method |
| 03/15/2006 | CA2515626A1 Pharmaceutical dosage forms with impeded extractability of a sympathomimetic from the dosage form |
| 03/14/2006 | US7012135 Genetic engineering; monoclonal antibody grafted to tumor necrosis factor |
| 03/14/2006 | US7012133 Antibodies to C-C chemokine Receptor 3 Protein |
| 03/14/2006 | US7012096 Comprising a weak organic acid such as acetic acid, vinegar, and/or citric acid dispersed within a carrier, at acidic pH, for treating burns; provides local analgesia |
| 03/14/2006 | US7012092 Formulation and delivery method to enhance antioxidant potency of Vitamin E |
| 03/14/2006 | US7012072 Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same |
| 03/14/2006 | US7012068 Reduced toxicity; enhance efficiency; side effect reduction |
| 03/14/2006 | US7012064 Cyclosporins for the treatment of immune disorders |
| 03/14/2006 | US7012062 Use of modified lysozyme C to prepare medicinal compositions for the treatment of some serious diseases |
| 03/14/2006 | US7011968 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 03/14/2006 | US7011854 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 03/14/2006 | US7011851 Drug delivery; incontinence therapy |
| 03/14/2006 | US7011846 Oral capsule formulation with increased physical stability |
| 03/14/2006 | US7011845 For therapy and prophylaxis of infection or tumor |
| 03/14/2006 | US7011825 Erythropoietin solution preparation |
| 03/14/2006 | US7011820 Delivery of compounds for the treatment of Parkinsons through an inhalation route |
| 03/14/2006 | US7011819 Increasing the rate at which the peak plasma concentrations are reached by delivering the drug in a single inspiration from a dispenser in which the condensation aerosol was formed by cooling a vapor formed by heating a thin layer on a support; less than 10% degradation products and a mass median aerosol |
| 03/14/2006 | US7011812 Targeted combination immunotherapy of cancer and infectious diseases |
| 03/14/2006 | US7011702 Made of non-crosslinked cellulose ether, select from alkyl cellulose, hydroxyalkyl cellulose, surfactant-free; agglomerating or coating solid particles, powder granulation; hair styling, foaming hand lotions and cleansers; high quality |
| 03/14/2006 | CA2312710C Sustained release formulation containing three different types of polymers and tablet formed therefrom |
| 03/14/2006 | CA2204027C Stabilized aqueous steroid immunoassay standards |
| 03/14/2006 | CA2127166C Sustained release morphine compositions and a method of preparation |
| 03/09/2006 | WO2006026471A2 Compositions and methods to lower glycohemoglobin levels |
| 03/09/2006 | WO2006026458A2 Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle |
| 03/09/2006 | WO2006026299A1 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b and other therapeutic proteins |
| 03/09/2006 | WO2006026215A1 Compositions containing alpha-2-adrenergic agonist components |
| 03/09/2006 | WO2006026185A2 Embolization |